FDA Approves Nerandomilast for Severe Lung Disease

Tablets for idiopathic pulmonary fibrosis are the first new treatment approved in more than 10 years.
Medscape Medical News

Source link : https://www.medscape.com/viewarticle/fda-gives-nod-nerandomilast-severe-lung-disease-2025a1000raw?src=rss

Author :

Publish date : 2025-10-09 19:23:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

FDA Approves Nerandomilast for Severe Lung Disease

NIH Leaders Fired, CDC Gets Acting Center Directors, and Prasad Shapes FDA Team

Palliative Endoscopic Procedure Bests Surgery for Malignant GI Obstruction

Related Posts

New H3N2 Variants May Challenge Flu Vaccines in 2025-2026

Do High-Fat Dairy Products Protect the Brain?

Pediatricians Fault Australia’s Social Media Ban for Teens

FDA OKs Subcutaneous Amivantamab for EGFR-Mutated NSCLC

Amyloid Testing Shows Minimal Effect on Lifestyle Changes

Smartwatches Help Parents Curb Kids’ Tantrums

New H3N2 Variants May Challenge Flu Vaccines in 2025-2026

Do High-Fat Dairy Products Protect the Brain?

Pediatricians Fault Australia’s Social Media Ban for Teens

FDA OKs Subcutaneous Amivantamab for EGFR-Mutated NSCLC

Amyloid Testing Shows Minimal Effect on Lifestyle Changes

Smartwatches Help Parents Curb Kids’ Tantrums

Mobile Tools Aid Weight Loss and Liver Wellness in NAFLD

Roman soldiers defending Hadrian’s Wall had intestinal parasites

Categories

Archives